Patents by Inventor Imran Ahmad
Imran Ahmad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9474727Abstract: The present invention relates to stable liquid pharmaceutical compositions of curcumin or its pharmaceutically acceptable salts or its derivatives with higher curcumin concentration and improved bioavailability without the use of buffer and/or molecular aggregation inhibitor(s). In accordance with present invention the curcumin is in the solubilized form to make a stable liquid pharmaceutical composition.Type: GrantFiled: September 12, 2011Date of Patent: October 25, 2016Assignee: Cadila Pharmaceuticals LimitedInventors: Bakulesh Mafatlal Khamar, Ashish Premkumar Gogia, Chirag Chandrakant Goda, Dinesh Balkunje Shenoy, Rajneesh Ramesh Shrivastava, Vandana Bharat Patravale, Indravadan Ambalal Modi, Ritu Nitin Laddha, Imran Ahmad Khan, Rajiv Indravadan Modi
-
Patent number: 9359721Abstract: Woven, unfinished textiles or yarns may be made softer and more brightly-colored by a method which comprises treating a yarn to weave fabric by sizing the yarn to weave fabric; desizing the sized fabric; bleaching the desized fabric; reducing the number of electrolytes on the bleached fabric; pre-softening the fabric having fewer electrolytes; fabric printing the pre-softened fabric; and finishing the fabric printed fabric. A fabric printed textile comprising a self cross-linked low glass transition temperature acrylic binder film on fibers of a fabric printed textile, where the fibers are impregnated with a polysiloxane polymer.Type: GrantFiled: March 13, 2013Date of Patent: June 7, 2016Assignee: WestPoint Home LLCInventors: Billy Harris, Imran Ahmad Cheema, Akram Shahzad, Gul Ahmad
-
Patent number: 9333190Abstract: The present invention provides compositions containing endoxifen, formulations and liposomes of endoxifen, methods of preparation of such agents and formulations, and use of such agents and formulations for the treatment of breast cancer and other breast diseases and diseases susceptible to endoxifen. In particular, the compositions of the present invention include liposomes, complexes, vesicles, emulsions, micelles and mixed micelles of endoxifen in which the compositions further contain any of a variety of neutral or charged lipids and desirably, cholesterol and cholesterol derivatives, sterols, Z- and E-guggulsterones, phospholipids, fatty acids, vitamin D, and vitamin E. The present invention also provides methods of preparing endoxifen. The present invention provides methods for treating and preventing breast cancer and other breast related diseases by administrating novel formulations or compositions comprising a therapeutically effective amount of endoxifen.Type: GrantFiled: November 21, 2007Date of Patent: May 10, 2016Assignee: JINA PHARMACEUTICALS, INC.Inventors: Ateeq Ahmad, Shoukath M. Ali, Moghis U. Ahmad, Saifuddin Sheikh, Imran Ahmad
-
Publication number: 20140259456Abstract: Woven, unfinished textiles or yarns may be made softer and more brightly-colored by a method which comprises treating a yarn to weave fabric by sizing the yarn to weave fabric; desizing the sized fabric; bleaching the desized fabric; reducing the number of electrolytes on the bleached fabric; pre-softening the fabric having fewer electrolytes; fabric printing the pre-softened fabric; and finishing the fabric printed fabric. A fabric printed textile comprising a self cross-linked low glass transition temperature acrylic binder film on fibers of a fabric printed textile, where the fibers are impregnated with a polysiloxane polymer.Type: ApplicationFiled: March 13, 2013Publication date: September 18, 2014Applicant: WestPoint Home LLCInventors: Billy Harris, Imran Ahmad Cheema, Akram Shahzad, Gul Ahmad
-
Patent number: 8298573Abstract: The invention provides a formulation of one or more antineoplastic drugs encapsulated in liposomes including at least a lipid fraction in addition to the antineoplastic drug, wherein the composition is stable in an aqueous solution at room temperature.Type: GrantFiled: August 3, 2005Date of Patent: October 30, 2012Inventors: Jia-Ai Zhang, Sydney Ugwu, Lan Ma, Gopal Anyarambhatla, Imran Ahmad
-
Publication number: 20120171383Abstract: A conformal coating apparatus is provided to deposit material on a substrate. The conformal coating apparatus includes a housing, a head configured to deposit material and a movement mechanism coupled to the housing and to the head. The movement mechanism includes a movable member coupled to the head, three actuators coupled to the housing, and three linkages respectively connecting the movable member to the three actuators. A controller is coupled to the movement mechanism and the head. The controller is configured to control the automated movement of the movement mechanism to provide at least x-axis, y-axis and z-axis movement of the head.Type: ApplicationFiled: December 30, 2010Publication date: July 5, 2012Applicant: Specialty Coating Systems, Inc.Inventors: Dennis Ronn Christensen, Imran Ahmad
-
Publication number: 20120164075Abstract: The present invention provides compositions containing endoxifen, formulations and liposomes of endoxifen, methods of preparation of such agents and formulations, and use of such agents and formulations for the treatment of a subject having or at risk for psychiatric and neurodegenerative diseases, infectious diseases, fertility disorders, osteoporosis, osteoarthritis, and/or cardiovascular diseases. Specifically, the present invention relates to compositions comprising endoxifen for use in the treatment of such disorders or predisposition to such disorders, for use in manufacture of medicaments for treating such disorders, and methods comprising use of such compositions in such treatments.Type: ApplicationFiled: May 21, 2010Publication date: June 28, 2012Applicant: JINA PHARMACEUTICALS, INC.Inventors: Ateeq Ahmad, Shoukath M. Ali, Moghis U. Ahmad, Saifuddin Sheikh, Imran Ahmad
-
Publication number: 20110212167Abstract: The present invention relates to the topical and oral delivery of a composition comprising one or more active agents for treating a disease or symptoms in a subject. In some embodiments, the present invention comprises a composition comprising at least one active compound, e.g., finasteride or minoxidil, and one or more lipids. In some embodiments, the present invention relates to composition and method of preparation for treating androgenic alopecia (AGA), prevention of hair loss and female hirsutism. In some embodiment, the present invention comprises finasteride and at least one lipid component for the treatment of benign prostatic hyperplasia. In some embodiment, the present invention comprises tacrolimus or amphotericin B and at least one lipid component for the treatment of skin or eye related diseases.Type: ApplicationFiled: September 25, 2009Publication date: September 1, 2011Applicant: JINA PHARMACEUTICALS, INC.Inventors: Shoukath M. Ali, Ateeq Ahmad, Moghis U. Ahmad, Saifuddin Sheikh, Imran Ahmad
-
Publication number: 20110104252Abstract: A gene that is a positive mediator of tumor growth and metastasis in certain cancer types is provided. This gene and corresponding polypeptide have diagnostic and therapeutic application for detecting and treating cancers that involve expression of SCC-S2 such as renal, ovarian, head and neck, breast, prostate, brain, chronic myelogenous leukemia, lung, lymphoblastic leukemia, and colorectal adenocarcinoma cells.Type: ApplicationFiled: August 17, 2010Publication date: May 5, 2011Applicant: GEORGETOWN UNIVERSITYInventors: USHA KASID, Deepak Kumar, Prafulla Gokhale, Imran Ahmad
-
Publication number: 20100323000Abstract: The invention provides novel methods for preparing cardiolipin and cardiolipin analogs having varying fatty acid chain lengths, particularly 1,1?,2,2?-tetramyristoyl cardiolipin. The methods comprise reacting a starting compound, such as a 1,2-O-sn-diacylglycerol and a 2-protected glycerol, with a phosphoramidite reagent to produce a protected cardiolipin, which is deprotected to prepare cardiolipin. The cardiolipin and cardiolipin analogs may be prepared in the presence of an activator, such as pyridinium trifluororacetate. The methods of the present invention are used to prepare cardiolipin and cardiolipin analogs in large quantities. The cardiolipin prepared by the present methods can be incorporated into liposomes which can also include active agents such as hydrophobic or hydrophilic drugs. Such liposomes can be used to treat diseases or in diagnostic and/or analytical assays.Type: ApplicationFiled: February 22, 2007Publication date: December 23, 2010Applicant: NEOPHARM, INC.Inventors: Shoukath M. Ali, Moghis U. Ahmad, Imran Ahmad
-
Publication number: 20100151002Abstract: The present invention relates to the methods for preparing synthetic guggulphospholipids, their fatty acid analogues and other bioactive molecules. The present invention relates to E-guggulsterone and Z-guggulsterone or mixture of E- and Z-guggulsterones. The present invention also provides a novel method for the preparation of E-guggulsterol and Z-guggulsterol or mixture of E- and Z-guggulsterols from a mixture of E- and Z-guggulsterones. The present invention further relates to guggulphospholipids and other bioactive molecules incorporated into complexes such as liposomes, complexes, emulsions, vesicles, micelles, and mixed micelles, which can include other active agents, such as hydrophobic or hydrophilic drugs for use, e.g., in treatment of human and animal diseases.Type: ApplicationFiled: November 6, 2007Publication date: June 17, 2010Applicant: JINA PHARMACEUTICALS, INC.Inventors: Moghis U. Ahmad, Shoukath M. Ali, Ateeq Ahmad, Saifuddin Sheikh, Imran Ahmad
-
Publication number: 20100112041Abstract: The present invention provides compositions containing endoxifen, formulations and liposomes of endoxifen, methods of preparation of such agents and formulations, and use of such agents and formulations for the treatment of breast cancer and other breast diseases and diseases susceptible to endoxifen. In particular, the compositions of the present invention include liposomes, complexes, vesicles, emulsions, micelles and mixed micelles of endoxifen in which the compositions further contain any of a variety of neutral or charged lipids and desirably, cholesterol and cholesterol derivatives, sterols, Z- and E-guggulsterones, phospholipids, fatty acids, vitamin D, and vitamin E. The present invention also provides methods of preparing endoxifen. The present invention provides methods for treating and preventing breast cancer and other breast related diseases by administrating novel formulations or compositions comprising a therapeutically effective amount of endoxifen.Type: ApplicationFiled: November 21, 2007Publication date: May 6, 2010Applicant: JINA PHARMACEUTICALS, INC.Inventors: Ateeq Ahmad, Shoukath M. Ali, Moghis U. Ahmad, Saifuddin Sheikh, Imran Ahmad
-
Publication number: 20100068251Abstract: The present invention relates to a methods of preparing active compounds complexed with lipids using aqueous systems that are free of organic solvents, and methods of using the complexes, e.g., in treating a disease in a subject. In some embodiments, the present invention comprises a composition comprising a complex comprising at least one active compound, e.g., a polyene antibiotic, an immunosuppressant agent such as tacrolimus or a taxane or taxane derivative, and one or more lipids. In some embodiments, the present invention provides a method comprising preparing a composition comprising a lipid complex comprising at least one active compound and at least one lipid and administering the composition to a subject. In certain embodiments the subject is a mammal. In certain preferred embodiments, the subject is human.Type: ApplicationFiled: October 10, 2007Publication date: March 18, 2010Applicant: JINA PHARMACEUTICALS, INC.Inventors: Shoukath M. Ali, Moghis U. Ahmad, Ateeq Ahmad, Saifuddin Sheikh, Imran Ahmad
-
Publication number: 20100041142Abstract: A gene that is a positive mediator of tumor growth and metastasis in certain cancer types is provided. This gene and corresponding polypeptide have diagnostic and therapeutic application for detecting and treating cancers that involve expression of SCC-S2 such as renal, ovarian, head and neck, breast, prostate, brain, chronic myelogenous leukemia, lung, lymphoblastic leukemia, and colorectal adenocarcinoma cells.Type: ApplicationFiled: May 18, 2009Publication date: February 18, 2010Applicant: Georgetown UniversityInventors: Usha Kasid, Deepak Kumar, Prafulla Gokhale, Imran Ahmad
-
Publication number: 20090317554Abstract: A spray coating apparatus for spraying material on a substrate includes a frame and a gantry coupled to the frame. The gantry may be configured to provide x-axis, y-axis and z-axis movement. A device is coupled to the gantry. The device may be configured to rotate about the z-axis and pivot about a point on the z-axis. A spray head is coupled to the device. A controller is coupled to the gantry and the spray head. The controller may be configured to control the automated movement of the gantry to provide x-axis, y-axis and z-axis movement and rotational and pivoting movement of the spray head. Other embodiments of the spray coating device and related methods are further disclosed.Type: ApplicationFiled: June 24, 2008Publication date: December 24, 2009Applicant: SPECIALTY COATING SYSTEMS, INC.Inventors: Dennis R. Christensen, Imran Ahmad, Joseph Wayne Brickell
-
Publication number: 20090291134Abstract: The present invention provides compositions containing endoxifen, formulations and liposomes of endoxifen, methods of preparation of such agents and formulations, and use of such agents and formulations for the treatment of a subject having or at risk for psychiatric and neurodegenerative diseases. Specifically, the present invention relates to the composition comprising endoxifen in the treatment of bipolar disorder, schizophrenia, multiple sclerosis (MS), Alzheimer disease, Parkinson disease, Huntington's disease, amyotrophic lateral sclerosis (ALS), and/or epilepsy by administrating formulations or compositions comprising an effective amount of endoxifen.Type: ApplicationFiled: May 21, 2009Publication date: November 26, 2009Applicant: JINA PHARMACEUTICALS, INC.Inventors: Ateeq Ahmad, Shoukath M. Ali, Moghis U. Ahmad, Saifuddin Sheikh, Imran Ahmad
-
Publication number: 20090011001Abstract: The present invention provides a manufacturing process for liposomal preparations comprising water-insoluble or hydrophobic active principals. In accordance with one aspect of the inventive method, at least one active principal and lipid fraction are dissolved in an organic solvent. This solution is then subjected to reduced pressure (vacuum) in a container with or with out inert packing to remove the organic solvent, thereby forming a puffy cake comprising the active principal or principals and lipid fraction. This puffy cake is then mixed with an aqueous solution, under controlled conditions suitable to form a bulk liposomal preparation. Because the active principal is imbedded in the lipid bilayer, removal of the aqueous solution is optional.Type: ApplicationFiled: October 28, 2005Publication date: January 8, 2009Inventors: Zafeer Ahmad, Gopal Anyarambhatla, Sushil Prem, Imran Ahmad
-
Publication number: 20080300418Abstract: The invention provides novel synthetic methodologies for preparing cardiolipin, migrated caridiolipin (1,2-positional isomer of cardiolipin) and their analogues having varying fatty acids and/or alkyl chains with varying length and degrees of saturation/unsaturation. The method comprises (a) reacting an optically pure 1,2-O-dialkyl-sn-glycerol or 1,2-O-dialkyl-sn-glycerol with one or more phosphoramidite reagent(s), wherein a phosphite triester is produced; (b) coupling the product of (a) with glycerol, wherein a protected cardiolipin is produced; and (c) deprotecting the protected cardiolipin, such that cardiolipin is prepared. The cardiolipins and analogues thereof, prepared by the present methods, can be incorporated into liposomes, which can also include active agents such as hydrophobic or hydrophilic drugs, antisense nucleotides or diagnostic agents. Such liposomes can be used to treat diseases or can be used in diagnostic and/or analytical assays.Type: ApplicationFiled: November 8, 2005Publication date: December 4, 2008Inventors: Moghis U. Ahmad, Murali K. Ukkalam, Shoukath M. Ali, Imran Ahmad
-
Publication number: 20080286351Abstract: The invention provides synthetic methods for PEGylated cardiolipins with varying linkers. The methods can be employed to prepare PEGylated cardiolipin with different fatty acid and/or alkyl chain length with or without unsaturation. The PEGylated cardiolipin, prepared by the present methods, can be incorporated into liposomes that can also include active agents such as hydrophilic or hydrophobic drugs for the treatment of human and animal diseases. In addition, the PEGylated cardiolipin can be incorporated into liposomes that include compounds for therapeutic and diagnostic imaging. The use of such liposomes with PEGylated cardiolipin prolongs the period of liposomal circulation without disrupting the lipid bilayer.Type: ApplicationFiled: June 29, 2005Publication date: November 20, 2008Inventors: Moghis U. Ahmad, Murali K. Ukkalam, Shoukath M. Ali, Imran Ahmad
-
Patent number: 7442520Abstract: A gene that is a modulator of tumor growth and metastasis in certain cancer types is provided. This gene and corresponding polypeptide have diagnostic and therapeutic application for detecting and treating cancers that involve expression of BRCC-3 such as breast cancer and lung cancer.Type: GrantFiled: October 6, 2003Date of Patent: October 28, 2008Assignee: Georgetown UniversityInventors: Usha Kasid, Prafulla Gokhale, Deepak Kumar, Howard Boudreau, Imran Ahmad, Anatoly Dritschilo, Aquilur Rahman